• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OncoMed Pharmaceuticals Inc

+ Add to Watchlist


22.9500 USD 0.9500 4.32%

As of 20:10:00 ET on 07/29/2014.

Snapshot for OncoMed Pharmaceuticals Inc (OMED)

Open: 22.4200 Day's Range: 21.8600 - 23.0000 Volume: 75,886
Previous Close: 22.0000 52wk Range: 12.0650 - 42.3400 1-Yr Rtn: +9.34%

Stock Chart for OMED

No chart data available.
  • OMED:US 22.9500
  • 1D
  • 1M
  • 1Y
Interactive OMED Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OMED

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.3153
Est. EPS (USD) (12/2014) -0.7640
Est. PEG Ratio -
Market Cap (M USD) 678.30
Shares Outstanding (M) 29.56
30 Day Average Volume 166,848
Price/Book (mrq) 6.4065
Price/Sale (ttm) 12.0693
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/03/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OMED

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OMED

OncoMed Pharmaceuticals Inc. provides biotechnology research and development. The Company synthesizes oncogenic mutations in stem cells that allows the cells to grow without normal limitations in attempts to exploit therapies that selectively target tumor initiating cells. OncoMed serves the healthcare industry and cancer therapy patients.

Paul J HastingsChairman/President/CEOJohn A LewickiExec VP/Chief Scientific Ofcr
Sunil PatelSenior VP:Corporate Dev/CFOJakob DupontSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for OMED

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil